Your Sorted CME/CE Activities

What's New in PH: Guidelines and Evidence for Improved Clinical Care
AMA/ANCC/ACPE Activity
This AMA/ANCC/ACPE activity features a recorded discussion among three leading pulmonary hypertension (PH) experts and is designed to keep healthcare professionals on top of the most recent clinical findings.

This activity provides an expert discussion around the updated guidelines from the European Society of Cardiology (ESC) and European Respiratory Society (ERS) as well as research presented at both ERS and CHEST 2022. These discussions provide the latest evidence for the care of patients with pulmonary hypertension based on data released from these conferences. Additionally, this activity also discusses the array of registry databases, what information has been yielded about the demographic factors, treatment, and survival of patients, as well as their limitations, which provides real-world evidence that informs clinical practice and health policy.
Review the activity and claim AMA, ANCC or ACPE credit/contact hour after completion of a brief pretest and posttest/evaluation.







Moderator:
Ronald Oudiz, MD Ronald Oudiz, MD, FACP, FACC, FCCP
Professor of Medicine
David Geffen School of Medicine at UCLA
Interim Chief, Division of Cardiology
Director, Liu Center for Pulmonary Hypertension
Ludquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Expert Faculty:
Marc Humbert, MD, PhD Marc Humbert, MD, PhD
Professor of Respiratory Medicine
Paris-Saclay University​
Director of the French Reference Centre for Pulmonary Hypertension
Hospital Bicêtre (Assistance Publique Hôpitaux de Paris)
Marion Delcroix, MD, PhD Marion Delcroix, MD, PhD
Professor of Medicine and of Respiratory Physiology
University of Leuven and Kortrijk
Head of Pulmonary Vascular Disease Program and Intermediate Respiratory Care Unit
University Hospitals of Leuven
   

20
Supported by independent educational grants from United Therapeutics Corporation, Bayer U.S. and Actelion Pharmaceuticals U.S., Inc., A Janssen Pharmaceutical Company of Johnson & Johnson

Launch Date: December 5, 2022
Release Date: December 5, 2022
Expiration Date: November 30, 2023

November 30, 2023
Mini Module
7502
ConversationsInPAH_WebBanner(1150).gif
Pulmonology